WWW - Posts tagged Secondary offering at BloggingStocks

secondary offering posts

Cramer on BloggingStocks: BB&T, Ford secondaries have real buyers

Posted May 13th 2009 9:40AM by Jim Cramer (RSS feed)
Filed under: Ford Motor (F), General Motors (GM), Market Matters, BB and T (BBT), Wells Fargo (WFC), Cramer on BloggingStocks

From TheStreet.com Network

TheStreet.com's Jim Cramer says he's a bit wary of both, but the pricing here is sound.

At least they knocked them down to where the shorts have to get in on the deals to cover. That's what I am thinking about BB&T (NYSE: BBT) (Cramer's Take) and Ford (NYSE: F) (Cramer's Take).

Both deals were widely telegraphed, so the shorts were able to really do a number on them. But I think because they were widely telegraphed and they had time to tell the story, both BB&T and Ford have real buyers even on the huge size of these deals --- Ford, especially -- which could make the shorts have to do some scrambling initially.

Continue reading Cramer on BloggingStocks: BB&T, Ford secondaries have real buyers

IPO & secondary preview - - Week of July 23, 2007

Posted Jul 24th 2007 8:45AM by Joseph Lazzaro (RSS feed)
Filed under: SEC Filings, Other Issues, Deals, Initial Public Offerings

Wall Street "takes a break from its summer break" to price several equity deals this week, with 8 IPOs and 1 secondary on the docket.

Those deals tentatively scheduled to price include:

IPOs:

Wednesday

Bladelogic (BLOG), a 5M-share IPO for this data center automation company. Morgan Stanley and Merrill Lynch are the lead managers. Filing range: $12.00-$14.00.
Monotype Imaging (TYPE), an 11M-share IPO for this text imaging company. The Bank of America is the lead manager. Filing range: $13.00-$15.00.
Rex Energy (REXX), a 14.7M-share IPO for this oil and gas company. KeyBanc Capital Markets is the lead manager. Filing range: $11.00-$13.00.
Validus (VR), a 15.7M-share IPO for this reinsurance services company. Goldman Sachs and Merrill Lynch are the lead managers. Filing range: $24.00-$26.00.
ImaRx Therapeutics (IMRX), a 3M-share IPO. Maxim Group and I-Bankers Securities are the lead managers. Filing price: $5.00.

Continue reading IPO & secondary preview - - Week of July 23, 2007